Pharmacy Times

JUNE 9, 2025

Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. Still, confusion remains over the role of pharmacy and therapeutics (P&T) committees in this process. This governance issue is a very hot topic,” Eric M.

Compounding Pharmacies 56

Compounding Pharmacies FDA Hospitals Immunization 56

Pharmacy Times

JULY 9, 2025

Mayo Clinic. FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease. Eli Lilly and Company. News release. July 9, 2025. Accessed July 9, 2025. Alzheimer’s Disease. News release. November 8, 2024. Accessed July 9, 2025. link] Gallagher A. Pharmacy Times.

Labelling 65

Labelling FDA Compounding Pharmacies Independent Pharmacies 65

Pharmacy Times

JUNE 26, 2025

In an interview with Pharmacy Times , Shaji Kumar, MD, consultant and research chair of the Division of Hematology in the Department of Internal Medicine at Mayo Clinic, discussed emerging data from the phase 2 RedirecTT-1 study (NCT04586426).

Compounding Pharmacies 65

Compounding Pharmacies Vaccines Immunization Mayo Clinic 65

Pharmacy Times

JULY 14, 2025

Mayo Clinic. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer.

FDA 73

FDA Compounding Pharmacies Compounding Immunization 73

Pharmacy Times

JUNE 24, 2025

LN is a complication of SLE that occurs when the immune system mistakenly attacks the kidneys, leading to inflammation and potential organ damage. This 200 mg/mL autoinjector was also approved for pediatric patients with active systemic lupus erythematosus (SLE) in 2024, according to a news release from GSK.

FDA 106

FDA Compounding Pharmacies Vaccines Immunization 106

Drug Topics

JUNE 24, 2025

1 “Having the Benlysta autoinjector provides a much-needed option that can help reduce the burden of frequent clinic visits for treatment and add greater flexibility for children and their families when considering continuity of care and routines of daily life." Mayo Clinic. REFERENCES 1. News release. June 24, 2025.

FDA 509

FDA Immunization Vaccines Mayo Clinic 509

Pharmacy Times

JUNE 19, 2025

1 "Immunotherapy given neoadjuvantly may not be the appropriate treatment strategy for patients with high fusion,” said Kaushal Parikh, MD, from Mayo Clinic. “In Mandatory ALK fusion testing should become part of the standard of care to better personalize treatments to a patient’s specific ALK variant.

Chemotherapy 73

Chemotherapy Compounding Pharmacies Hospitals Immunization 73

Pharmacy Times

JUNE 15, 2025

Following, HR+, HER2- early breast cancer is a common subtype where the cancer cells have estrogen and progesterone receptors but do not have excessive amounts of the HER2 protein, according to Mayo Clinic.

Mayo Clinic 106

Mayo Clinic Compounding Pharmacies Immunization Compounding 106

Drug Topics

JULY 16, 2025

Mayo Clinic. McKesson Series: Using Technology to Simplify Vaccination Programs December 22nd 2020 Podcast Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others. Self-reported resilience during the COVID-19 pandemic. JAMA Netw Open.

Specialty Pharmacies 316

Specialty Pharmacies Independent Pharmacies Compounding Vaccines 316

Pharmacy Times

JUNE 9, 2025

Mayo Clinic. Akkooi A, Mandala M, Kicinski M, Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation. J Clin Oncol. 43, 2025 (suppl 17; abstr LBA9500). doi:10.1200/JCO.2025.43.17_suppl.LBA9500.

Compounding Pharmacies 82

Compounding Pharmacies Immunization Mayo Clinic Compounding 82

Pharmacy Times

JULY 18, 2025

Mayo Clinic. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. JAMA Netw Open. 2025;8(7):e2520011. doi:10.1001/jamanetworkopen.2025.20011 2025.20011 2. Long-term obesity and biological aging in young adults. EuerkAlert!

Compounding Pharmacies 73

Compounding Pharmacies Compounding Immunization Mayo Clinic 73

Pharmacy Times

JULY 14, 2025

Mayo Clinic. " 1 REFERENCES 1. Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System. News release. July 7, 2025. Accessed July 7, 2025. Atrial fibrillation. Accessed July 7, 2025. Boston Scientific. FARAPULSE™ Pulsed Field Ablation System. Accessed July 7, 2025.

Labelling 65

Labelling FDA Compounding Pharmacies Hospitals 65

The Checkup by Singlecare

SEPTEMBER 22, 2023

This year, there are new vaccines to help at-risk populations ward off severe sickness, including that caused by RSV. Here’s what you need to know about the new FDA-approved RSV vaccine. But young children, older adults, and individuals with weakened immune systems are at high risk of severe, potentially life-threatening RSV illness.

Vaccines 105

Vaccines Immunization Insurance FDA 105

Pharmaceutical Technology

MAY 15, 2023

Its platform has capabilities to be used in combination with CAR-T and other cell therapies to overcome poor immune cell infiltration, immunosuppressive properties of tumour microenvironment, and systematic toxicity issues. The company has an operational presence in the US and the UK (headquartered in Abingdon, Oxfordshire, UK).

Mayo Clinic 52

Mayo Clinic Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies 52

SingleCare

JANUARY 2, 2020

Keep up-to-date on immunizations. associate director of Clinical Pharmacy at the University of Southern California School of Pharmacy in Los Angeles says they also administer immunizations recommended by the Centers for Disease Control and Prevention (CDC) including shingles , Tdap (tetanus, diphtheria and pertussis), HPV and pneumonia.

Mayo Clinic 52

Mayo Clinic Vaccines Immunization Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These can serve as an important component of a vaccine.

Mayo Clinic 59

Mayo Clinic Immunization Vaccines Pharmaceutical Companies 59

The Checkup by Singlecare

JANUARY 11, 2024

The lymph nodes tend to swell when they react to an infection or a vaccine. You may even notice armpit pain after a COVID-19 vaccine. If you have pain in the left armpit, and that’s the same arm you had your vaccine, it could simply be a sign that your immune response has kicked in and the vaccine is working.

Mayo Clinic 52

Mayo Clinic Vaccines Immunization 52

The Checkup by Singlecare

OCTOBER 10, 2023

Cephalexin and probiotics or oral live vaccines This one makes perfect sense. Oral live vaccines contain weakened bacteria, such as typhoid and cholera. These bacteria stimulate our immunity, but if given concurrently with an antibiotic, the bacteria from the vaccine could be eradicated before they have done their job.

Mayo Clinic 52

Mayo Clinic Vaccines Labelling Medical Records 52

The Checkup by Singlecare

OCTOBER 6, 2023

Key takeaways: Methylprednisolone is an effective therapeutic agent to control immune responses and inflammation. Some interactions go beyond medications; certain foods can also affect methylprednisolone’s effectiveness.

Vaccines 52

Vaccines Mayo Clinic FDA Immunization 52